New troglitazone derivatives devoid of PPAR agonist activity display an increased antiproliferative effect in both hormone-dependent and hormone-independent breast cancer cell lines

Author: Colin Christelle   Salamone Stéphane   Grillier-Vuissoz Isabelle   Boisbrun Michel   Kuntz Sandra   Lecomte Julie   Chapleur Yves   Flament Stéphane  

Publisher: Springer Publishing Company

ISSN: 0167-6806

Source: Breast Cancer Research and Treatment, Vol.124, Iss.1, 2010-11, pp. : 101-110

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content